Ozempic is manufactured by Novo Nordisk, a Danish multinational pharmaceutical company. Key manufacturing locations for Ozempic include a major facility in Kalundborg, Denmark, where Novo Nordisk has had a factory for over 55 years and is investing heavily to increase production. Additionally, Novo Nordisk is expanding manufacturing capacity with new and existing plants in Ireland (Athlone) and in the United States, specifically in North Carolina (Johnston County/Clayton area). These facilities produce semaglutide, the active ingredient in Ozempic, to meet global demand.
